Cargando…

Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene

Farnesoid X receptor (FXR, encoded by NR1H4), a bile acid‐activated nuclear receptor, is widely implicated in human tumorigenesis. The FXR agonist obeticholic acid (OCA) has preliminarily displayed tumour suppressor potential. However, the anticancer effects of this agent on colorectal cancer (CRC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shan, Xu, Zhengshui, Guo, Jing, Zheng, Jianbao, Sun, Xuejun, Yu, Junhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754034/ https://www.ncbi.nlm.nih.gov/pubmed/33164339 http://dx.doi.org/10.1111/jcmm.16083

Ejemplares similares

Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
por: Yu, Junhui, et al.
Publicado: (2020)

CDX2 inhibits epithelial–mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression
por: Yu, Junhui, et al.
Publicado: (2020)

Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
por: Yu, Junhui, et al.
Publicado: (2020)

Knockdown of MMP-1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c-myc signaling pathway and EMT
por: Wang, Kai, et al.
Publicado: (2020)

Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity
por: Wunderlich, Claudia M., et al.
Publicado: (2013)

Involvement of JAK-STAT-SOCS3 Pathway in the Regression of Mice X-Zone of Adrenal Cortex
por: Auricino, Thais Barabba, et al.
Publicado: (2021)

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling
por: Liu, Ze-Kun, et al.
Publicado: (2021)

Curcumin Suppressed Activation of Dendritic Cells via JAK/STAT/SOCS Signal in Mice with Experimental Colitis
por: Zhao, Hai-Mei, et al.
Publicado: (2016)

Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
por: Yang, Xilan, et al.
Publicado: (2020)

The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology
por: Sims, Natalie A.
Publicado: (2020)

t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5
por: Ehrentraut, Stefan, et al.
Publicado: (2013)

The molecular basis of JAK/STAT inhibition by SOCS1
por: Liau, Nicholas P. D., et al.
Publicado: (2018)

CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression
por: Yu, Junhui, et al.
Publicado: (2019)

SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway
por: Chen, Mo, et al.
Publicado: (2020)

Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway
por: Zhang, Yi, et al.
Publicado: (2012)

LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway
por: Gong, Haoli, et al.
Publicado: (2023)

miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling
por: Collins, Aideen S., et al.
Publicado: (2013)

The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
por: Han, Xianwei, et al.
Publicado: (2023)

Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role
por: Yu, Junhui, et al.
Publicado: (2021)

SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling
por: Li, Cong, et al.
Publicado: (2016)

Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis
por: Tschuck, Juliane, et al.
Publicado: (2023)

Inhibition of lncRNA DILC attenuates neuropathic pain via the SOCS3/JAK2/STAT3 pathway
por: Liu, Yujie, et al.
Publicado: (2020)

Implication of JAK1/STAT3/SOCS3 Pathway in Aging of Cerebellum of Male Rat: Histological and Molecular study
por: Mohamed, Enas Ahmed, et al.
Publicado: (2020)

SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
por: Pandey, Rahul, et al.
Publicado: (2023)

SOCS3 Promotes ALV-J Virus Replication via Inhibiting JAK2/STAT3 Phosphorylation During Infection
por: Mo, Guodong, et al.
Publicado: (2021)

Effect of SOCS3 on apoptosis of human trophoblasts via adjustment of the JAK2/STAT3 signaling pathway in preterm birth
por: Yin, Yin, et al.
Publicado: (2021)

Stat3 enhances transactivation of steroid hormone receptors
por: de Miguel, Fernando, et al.
Publicado: (2003)

STAT3 enhances the constitutive activity of AGC kinases in melanoma by transactivating PDK1
por: Picco, María Elisa, et al.
Publicado: (2019)

Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2017)

Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy
por: Liu, Hui-Min, et al.
Publicado: (2021)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

miRNA-331-3p Affects the Proliferation, Metastasis, and Invasion of Osteosarcoma through SOCS1/JAK2/STAT3
por: Zu, Dan, et al.
Publicado: (2022)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022)

Bacterial metabolites directly modulate farnesoid X receptor activity
por: Zhang, Xianqin, et al.
Publicado: (2015)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
por: Cao, Shan, et al.
Publicado: (2021)

LINC00669 insulates the JAK/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion
por: Qing, Xiang, et al.
Publicado: (2020)

Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1
por: You, Wenjie, et al.
Publicado: (2017)

Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells
por: Xiong, Haojun, et al.
Publicado: (2017)

Protective effects of SOCS3 overexpression in high glucose-induced lung epithelial cell injury through the JAK2/STAT3 pathway
por: Duan, Wei-Na, et al.
Publicado: (2017)

Association analysis of SOCS3, JAK2 and STAT3 gene polymorphisms and genetic susceptibility to type 2 diabetes mellitus in Chinese population
por: Zhang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rp2qqs3pamdk4ouc7ub3d03k67